Kari J. Kurppa

Turku, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis.

The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis.

Journal: Leukemia

Published: July 21, 2025

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies.

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies.

Journal: Molecular oncology

Published: July 04, 2025

Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germ line ERCC6L2 disease.

Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germ line ERCC6L2 disease.

Journal: Blood

Published: June 06, 2025

Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germline ERCC6L2 disease.

Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germline ERCC6L2 disease.

Journal: Blood

Published: June 06, 2025

Complement components C1r and C1s promote oral squamous cell carcinoma cell proliferation.

Complement components C1r and C1s promote oral squamous cell carcinoma cell proliferation.

Journal: Journal of oral biosciences

Published: April 23, 2025

Database of recurrent mutations, an unbiased web resource to browse recurrent mutations in cancers.

Database of recurrent mutations, an unbiased web resource to browse recurrent mutations in cancers.

Journal: iScience

Published: March 09, 2025

LIMA1-alpha staining predicts curative intent surgery response in HPV negative head and neck cancer.

LIMA1-alpha staining predicts curative intent surgery response in HPV negative head and neck cancer.

Journal: EMBO molecular medicine

Published: October 21, 2024

The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect.

The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect.

Journal: Cancer research

Published: April 05, 2024

Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth In Vivo.

Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth In Vivo.

Journal: Chembiochem : a European journal of chemical biology

Published: March 21, 2024

Wnt/β-catenin-YAP axis in the pathogenesis of primary intraosseous carcinoma NOS, deriving from odontogenic keratocyst.

Wnt/β-catenin-YAP axis in the pathogenesis of primary intraosseous carcinoma NOS, deriving from odontogenic keratocyst.

Journal: Pathology, research and practice

Published: March 18, 2024

Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication.

Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication.

Journal: Pathology, research and practice

Published: December 19, 2023

DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer.

DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer.

Journal: EMBO molecular medicine

Published: September 04, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026